BACKGROUND: This study was designed to evaluate the prognostic significance of the positivity of lymphovascular (LVI) and perineural invasion (PNI) in patients with locally advanced colorectal cancer. METHODS: From January 1999 to December 2009, 1,437 consecutive patients who underwent curative surgery for stage II or III colorectal cancer were analyzed. Patients were then categorized into 4 groups: LVI-/PNI- (n = 850), LVI+ only (n = 178), PNI+ only (n = 271), and LVI+/PNI+ (n = 138). RESULTS: With a median follow-up period of 56 months, the 5-year overall survival rates of patients with LVI-/PNI-, LVI+ only, PNI+ only, and LVI+/PNI+ were 82%, 73%, 71%, and 56%, respectively (P < .001), and the 5-year disease-free survival rates of patients with LVI-/PNI-, LVI+ only, PNI+ only, and LVI+/PNI+ were 80%, 70%, 65%, and 46%, respectively (P < .001). In multivariate analysis, LVI+/PNI+ was an independent prognostic factor for both overall survival (P < .001) and disease-free survival (P < .001). CONCLUSIONS: Positivity of both LVI and PNI is a strong predictor of overall and disease-free survival in patients with stages II and III colorectal cancer.
BACKGROUND: This study was designed to evaluate the prognostic significance of the positivity of lymphovascular (LVI) and perineural invasion (PNI) in patients with locally advanced colorectal cancer. METHODS: From January 1999 to December 2009, 1,437 consecutive patients who underwent curative surgery for stage II or III colorectal cancer were analyzed. Patients were then categorized into 4 groups: LVI-/PNI- (n = 850), LVI+ only (n = 178), PNI+ only (n = 271), and LVI+/PNI+ (n = 138). RESULTS: With a median follow-up period of 56 months, the 5-year overall survival rates of patients with LVI-/PNI-, LVI+ only, PNI+ only, and LVI+/PNI+ were 82%, 73%, 71%, and 56%, respectively (P < .001), and the 5-year disease-free survival rates of patients with LVI-/PNI-, LVI+ only, PNI+ only, and LVI+/PNI+ were 80%, 70%, 65%, and 46%, respectively (P < .001). In multivariate analysis, LVI+/PNI+ was an independent prognostic factor for both overall survival (P < .001) and disease-free survival (P < .001). CONCLUSIONS: Positivity of both LVI and PNI is a strong predictor of overall and disease-free survival in patients with stages II and III colorectal cancer.
Authors: Katelin A Mirkin; Christopher S Hollenbeak; Ali Mohamed; Yuxia Jia; Wafik S El-Deiry; Evangelos Messaris Journal: Cancer Biol Ther Date: 2017-05-05 Impact factor: 4.742
Authors: Bruno Märkl; Maximilian Märkl; Tina Schaller; Patrick Mayr; Gerhard Schenkirsch; Bernadette Kriening; Matthias Anthuber Journal: Cancer Med Date: 2016-05-11 Impact factor: 4.452